To validate FSP1 as a central target of ginsenoside RK1-mediated ferroptosis in hepatocellular carcinoma, we engineered overexpression plasmids for GCH1, DHODH, GPX4, and FSP1, respectively, and transfected them into HepG2 cells. The gene discussed is GPX4; the disease is hepatocellular carcinoma.